Task: Answer the multiple-choice question.
Query: Which drug exhibits a -21.106% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. O=C(NCc1ccncc1)C(=O)NCc1ccncc1
b. COc1cc(C)ccc1Oc1nc(-c2ccccc2O)nc2ccccc12
c. Clc1cc(Br)ccc1NCc1cccnc1
d. CSc1ccc(CNC(=O)c2ccc(NC(=O)C3=CSCCO3)cc2)cc1
e. Nn1c(COc2ccccc2F)nnc1SCC(=O)NC1CCS(=O)(=O)C1
Answer: c. Clc1cc(Br)ccc1NCc1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1cc(Br)ccc1NCc1cccnc1
Clc1cc(Br)ccc1NCc1cccnc1
4-bromo-2-chloro-N-(pyridin-3-ylmethyl)aniline